NutraStar Awarded Patent Allowing 26 Claims For Novel Anti-Inflammatory/Anti-Arthritic Formula

EL DORADO HILLS, Calif., Jan. 27 /PRNewswire-FirstCall/ -- NutraStar(TM) Incorporated (OTC Bulletin Board: NTRA; Berlin Exchange: NTQ) announced today that they have received notification from the United States Patent and Trademark Office of the allowance of U.S. Patent Application No. 10/012270, a patent for treating inflammation and pain in mammals, specifically covering humans, horses, dogs and cats. NutraStar has developed an impressive line of its novel anti-inflammatory/anti-arthritic formulations and products based upon the science underlying this patent.

In 2001, NutraStar, W. F. Young Company, manufacturer of the Absorbine line of premium equine products, and Wolcott Farms, owner of the NaturalGlo line of stabilized rice bran supplements for horses concluded a clinical trial conducted on 50 horses suffering from inflammation and lameness. This trial was conducted by noted equine veterinarian, Dr. Gary Kaufmann of Scottsdale, Arizona. W. F. Young and NutraStar have entered into a strategic alliance, developing innovative nutraceutical products designed to improve the quality of life and the health of horses and humans. NutraStar has formulated a complete line of products for the Absorbine Flex+ label.

Dr. Harry Hayes, Vice President - Business Development for W. F. Young, Inc. stated, "W.F. Young, Inc., the makers of the Absorbine and Absorbine Jr. range of products, is very pleased and gratified by this excellent news. During the past three years, we have worked with NutraStar on the development of a number of products protected under this patent. For the past 16 months, we have been marketing one of the products under the 'Flex +' brand name. 'Flex +' has been a very successful franchise for us. We know the products work because of our clinical trial. Our consumers confirm that 'Flex +' is providing a tremendous benefit to their animals. It's reassuring to know that our investment in this product line has the full protection of a U.S. patent and soon-to-be worldwide patent. It provides us with a great platform upon which to further build upon this success. We look forward to marketing new and cutting-edge products developed by NutraStar based upon hard science-based research, resulting in peer-reviewed papers and patents such as this. We congratulate our business partner, NutraStar, on achieving this significant milestone."

NutraStar's novel anti-inflammatory/anti-arthritic formulations are comprised of its proprietary stabilized rice bran whole food complexes. The resulting products, the Absorbine Flex+ line, the Absorbine Jr. line and NutraFlex line of products, provide a safe and effective method for reducing pain around the joints and improving mobility in humans, horses, dogs, cats and other mammals. Several variations of the formulation have been developed into products at the Company's Corporate Research Center in El Dorado Hills, California. These products include powdered drinks, capsules, topical creams, nutritional bars and food supplements.

"We are so gratified to receive such a broad-based patent. These breakthrough products and formulations upon which these claims are based have the potential to benefit millions of people suffering from joint pain, inflammation and arthritic conditions, not only in the United States but throughout the world," stated Patricia McPeak, NutraStar's founder, Chairman, CEO and the Principal Inventor of this patent. "While we're still analyzing the breadth and scope of this patent, I wish to extend my thanks to our exceptional team of dedicated researchers. With intend to fully capitalize on the opportunity to develop products which will have a profoundly beneficial effect on a variety of inflammatory-related diseases for humans and animals."

NutraStar is an emerging health sciences company focusing on the development and distribution of its nutraceutical "super food" products, products for promoting health by improving the nutritional status of people and animals suffering from Type 1 and Type 2 diabetes, coronary heart disease, as well as providing natural arthritic relief products and "all natural" cosmetics, natural creams, lotions and beauty aids for both humans and animals. The company is headquartered at 1261 Hawk's Flight Court, El Dorado Hills, California 95762.

Interested persons are encouraged to visit the company's website at

This release contains statements that are forward looking. These statements are made based upon current expectations that are subject to risk and uncertainty. The Company does not undertake to update forward-looking statements in this news release to reflect actual results, changes in assumptions or changes in other factors affecting such forward-looking information. Assumptions and other information that could cause results to differ from those set forth in the forward-looking information can be found in the Company's filings with the Securities and Exchange Commission, including the company's most recent periodic report.

Hide comments


  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.